Derivation of Diverse Hormone-Releasing Pituitary Cells from Human Pluripotent Stem Cells.
Derivation of Diverse Hormone-Releasing Pituitary Cells from Human Pluripotent Stem Cells.
复制标题
从人类多能干细胞中衍生出多种释放激素的垂体细胞。
DOI:
10.1016/j.stemcr.2016.05.005
复制
发表时间:
2016-06-14
影响因子:
5.9
通讯作者:
Studer L
中科院分区:
文献类型:
--
作者:
Zimmer B;Piao J;Ramnarine K;Tomishima MJ;Tabar V;Studer L
Human pluripotent stem cells (hPSCs) provide an unlimited cell source for regenerative medicine. Hormone-producing cells are particularly suitable for cell therapy, and hypopituitarism, a defect in pituitary gland function, represents a promising therapeutic target. Previous studies have derived pituitary lineages from mouse and human ESCs using 3D organoid cultures that mimic the complex events underlying pituitary gland development in vivo. Instead of relying on unknown cellular signals, we present a simple and efficient strategy to derive human pituitary lineages from hPSCs using monolayer culture conditions suitable for cell manufacturing. We demonstrate that purified placode cells can be directed into pituitary fates using defined signals. hPSC-derived pituitary cells show basal and stimulus-induced hormone release in vitro and engraftment and hormone release in vivo after transplantation into a murine model of hypopituitarism. This work lays the foundation for future cell therapy applications in patients with hypopituitarism. Defined, cGMP-ready protocol to derive anterior pituitary-lineage cells from hPSCs FGF8 and BMP2 patterning enables enrichment for specific hormone-producing cells Pituitary cells secrete multiple hormones and respond to physiological stimuli hPSC-pituitary cells partially rescue a rat model of hypopituitarism In this article, Studer and colleagues present the derivation of anterior pituitary cells from hPSCs under cGMP-ready monolayer conditions by mimicking in vivo developmental patterning cues. Single-cell gene-expression analysis confirms identity and diversity of in vitro generated pituitary cells. The generated cells are functional in vitro and capable of partially rescuing a rat model of hypopituitarism.